The metabolic control and laboratory evaluation in patients with type 2 diabetes during the COVID-19 pandemic and the impact of telemedicine: a single-center experience

1. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020 Mar 19;91(1):157-60. DOI: 10.23750/abm.v91i1.9397756957332191675 Open DOISearch in Google Scholar

2 Buicu AL, Cernea S, Benedek I, Buicu CF, Benedek T. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity. J Clin Med. 2021 Apr 7;10(8):1545. DOI: 10.3390/jcm10081545806763133916917 Open DOISearch in Google Scholar

3. Shivalkar S, Pingali MS, Verma A, Singh A, Singh V, Paital B, et al. Outbreak of COVID-19: A Detailed Overview and Its Consequences. Adv Exp Med Biol. 2021;1353:23-45. DOI: 10.1007/978-3-030-85113-2_235137366 Open DOISearch in Google Scholar

4. WHO Coronavirus (COVID-19) Dashboard. Available at https://covid19.who.int/. Accessed on 05.10.2022. Search in Google Scholar

5. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). 2022 Jun 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. PMID: 32150360. Search in Google Scholar

6. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct;53(10):737-54. DOI: 10.1080/23744235.2021.1924397814629834024217 Open DOISearch in Google Scholar

7. Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022 Jun;65(6):949-54. DOI: 10.1007/s00125-022-05670-0892374335292829 Open DOISearch in Google Scholar

8. Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care. 2021 Dec;44(12):2645-55. DOI: 10.2337/dc21-1318866953634625431 Open DOISearch in Google Scholar

9. Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021 Feb;37(2):e3377. DOI: 10.1002/dmrr.3377736120132588943 Open DOISearch in Google Scholar

10. Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. DOI: 10.1016/j.cmet.2020.04.021725216832369736 Open DOISearch in Google Scholar

11. Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020 Jul;14(4):813-21. DOI: 10.1177/1932296820924469767315032389027 Open DOISearch in Google Scholar

12. Peric S, Stulnig TM. Diabetes and COVID-19: Disease-Management-People. Wien Klin Wochenschr. 2020 Jul;132(13-14):356-61. DOI: 10.1007/s00508-020-01672-3723839932435867 Open DOISearch in Google Scholar

13. Desvars-Larrive A, Dervic E, Haug N, Niederkrotenthaler T, Chen J, Di Natale A, et al. A structured open dataset of government interventions in response to COVID-19. Sci Data. 2020 Aug 27;7(1):285. DOI: 10.1101/2020.05.04.20090498 Open DOISearch in Google Scholar

14. Scott ES, Jenkins AJ, Fulcher GR. Challenges of diabetes management during the COVID-19 pandemic. Med J Aust. 2020 Jul;213(2):56-57. DOI: 10.5694/mja2.5066532583422 Open DOISearch in Google Scholar

15. Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021 Sep 7;13(1):95. DOI: 10.1186/s13098-021-00705-9842333734493317 Open DOISearch in Google Scholar

16. Garfan S, Alamoodi AH, Zaidan BB, Al-Zobbi M, Hamid RA, Alwan JK, et al. Telehealth utilization during the Covid-19 pandemic: A systematic review. Comput Biol Med. 2021 Nov;138:104878. DOI: 10.1016/j.compbiomed.2021.104878845004934592585 Open DOISearch in Google Scholar

17. de Kreutzenberg SV. Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience. High Blood Press Cardiovasc Prev. 2022 Jul;29(4):319-26. DOI: 10.1007/s40292-022-00524-7911195035579849 Open DOISearch in Google Scholar

18. Phillip M, Bergenstal RM, Close KL, Danne T, Garg SK, Heinemann L, et al. The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction. Diabetes Technol Ther. 2021 Feb;23(2):146-54. DOI: 10.1089/dia.2020.0375809876732905711 Open DOISearch in Google Scholar

19. Tanji Y, Sawada S, Watanabe T, Mita T, Kobayashi Y, Murakami T, et al. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown. Diabetes Res Clin Pract. 2021 Jun;176:108840. DOI: 10.1016/j.diabres.2021.108840808461333933499 Open DOISearch in Google Scholar

20. Biamonte E, Pegoraro F, Carrone F, Facchi I, Favacchio G, Lania AG, et al. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine. 2021 Jun;72(3):604-10. DOI: 10.1007/s12020-021-02739-5809863933950348 Open DOISearch in Google Scholar

21. Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study. Int J Diabetes Dev Ctries. 2020 Oct;40(4):476-81. DOI: 10.1007/s13410-020-00880-x757697733106739 Open DOISearch in Google Scholar

22. Selek A, Gezer E, Altun E, Sözen M, Topaloğlu Ö, Köksalan D, et al. The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli. J Diabetes Metab Disord. 2021 Aug 27;20(2):1461-7. DOI: 10.1007/s40200-021-00888-y839378334466406 Open DOISearch in Google Scholar

23. Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021 Sep 7;13(1):95. DOI: 10.1186/s13098-021-00705-9842333734493317 Open DOISearch in Google Scholar

24. Ojo O, Wang XH, Ojo OO, Orjih E, Pavithran N, Adegboye ARA, et al. The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 Jan 19;19(3):1095. DOI: 10.3390/ijerph19031095883431335162117 Open DOISearch in Google Scholar

25. Wong VW, Wang A, Manoharan M. Utilisation of telehealth for outpatient diabetes management during COVID-19 pandemic: how did the patients fare? Intern Med J. 2021 Dec;51(12):2021-6. DOI: 10.1111/imj.15441844701234227718 Open DOISearch in Google Scholar

26. Hansel B, Potier L, Chalopin S, Larger E, Gautier JF, Delestre F, et al. The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort. Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2605-11. DOI: 10.1016/j.numecd.2021.05.031918790334348875 Open DOISearch in Google Scholar

27. Hartmann B, Tittel SR, Femerling M, Pfeifer M, Meyhöfer S, Lange K, et al. COVID-19 Lockdown Periods in 2020: Good Maintenance of Metabolic Control in Adults with Type 1 and Type 2 Diabetes. Exp Clin Endocrinol Diabetes. 2022 Sep;130(9):621-6. DOI: 10.1055/a-1743-253735181878 Open DOISearch in Google Scholar

28. Endo K, Miki T, Itoh T, Kubo H, Ito R, Ohno K, et al. Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan. Intern Med. 2022;61(1):37-48. DOI: 10.2169/internalmedicine.8041-21881025634980759 Open DOISearch in Google Scholar

29. Celik M, Yilmaz Y, Karagoz A, Kahyaoglu M, Cakmak EO, Kup A, et al. Anxiety Disorder Associated with the COVID-19 Pandemic Causes Deterioration of Blood Pressure Control in Primary Hypertensive Patients. Medeni Med J. 2021;36(2):83-90. DOI: 10.5222/MMJ.2021.08364822640334239759 Open DOISearch in Google Scholar

30. Laffin LJ, Kaufman HW, Chen Z, Niles JK, Arellano AR, Bare LA, et al. Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic. Circulation. 2022 Jan 18;145(3):235-7. DOI: 10.1161/CIRCULATIONAHA.121.057075876304434865499 Open DOISearch in Google Scholar

31. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021 Nov 6;398(10312):1700-12. DOI: 10.1016/S0140-6736(21)02143-7850069734634250 Open DOISearch in Google Scholar